Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 9:52 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 127 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Heart Transplant Surgery Clear all

Conditions: Coronary Disease, Cardiovascular Diseases, Heart Diseases, Neurologic Manifestations
Interventions: Estrogen Replacement Therapy, Surgery; Drug · Procedure
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 55 Years and older · Female only
Enrollment: 334 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2005
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Coronary Artery Disease
Interventions: Not listed
Lead sponsor: Sapere Bio; Industry
Eligibility: 50 Years and older
Enrollment: 186 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Coronary Artery Disease
Interventions: Hybrid CABG/PCI, Off Pump CABG; Procedure
Lead sponsor: Pinnacle Health Cardiovascular Institute; Network
Eligibility: Not listed
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2019
U.S. locations: 1
States / cities: Harrisburg, Pennsylvania

Conditions: Cerebral Autoregulation Impairment, Postoperative Cognitive Dysfunction, Postoperative Delirium
Interventions: BrainProtect System, Standard perioperative management; Device · Procedure
Lead sponsor: Scienceforbrain, UAB; Industry
Eligibility: 18 Years to 69 Years
Enrollment: 304 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Coronary Artery Disease, Heart Diseases
Interventions: Single arterial graft, Multiple arterial grafting; Procedure
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 4,300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2030
U.S. locations: 11
States / cities: Boulder, Colorado • Springfield, Massachusetts • Lincoln, Nebraska + 5 more

Conditions: Coronary Artery Bypass Grafting
Interventions: BoneSeal, Ostene; Device
Lead sponsor: Loma Linda University; Other
Eligibility: 45 Years and older
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Coronary Artery Bypass Grafting, Mitral Valve Surgery, Low Cardiac Output Syndrome
Interventions: Levosimendan, Placebo; Drug
Lead sponsor: Tenax Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 882 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 49
States / cities: Burlington, Alabama • Huntsville, Alabama • Sacramento, California + 41 more

Conditions: Blood Recovery
Interventions: Hand Wrung, ProCell Wrung; Procedure · Device
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years to 89 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Coronary Heart Disease, Graft Occlusion, Vascular
Interventions: Placebo, RO4905417; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 384 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 27
States / cities: Huntsville, Alabama • Tucson, Arizona • Los Angeles, California + 21 more

Conditions: Coronary Artery Disease
Interventions: FFR-guided PCI, CABG; Procedure
Lead sponsor: Stanford University; Other
Eligibility: 21 Years and older
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Stanford, California

Conditions: Poor Glycemic Control
Interventions: Metformin, Glargine insulin, Glulisine; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 175 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 3
States / cities: Atlanta, Georgia

Conditions: Advanced Heart Failure, Ischemic Heart Failure
Interventions: HiCM-188 Cells; Drug
Lead sponsor: HELP Therapeutics, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Coronary Artery Disease
Interventions: Not listed
Lead sponsor: Tufts Medical Center; Other
Eligibility: 20 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Coronary Artery Disease
Interventions: Coronary artery bypass grafting (CABG), Percutaneous coronary intervention (PCI); Procedure
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2039
U.S. locations: 18
States / cities: Glendale, California • Atlanta, Georgia • Carmel, Indiana + 12 more

Conditions: Pain
Interventions: Parecoxib Sodium/Valdecoxib, Placebo/Valdecoxib, Placebo/Placebo; Drug · Other
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 1,671 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 84
States / cities: Fairhope, Alabama • Mobile, Alabama • Tucson, Arizona + 61 more

Conditions: Blood Recovery
Interventions: Hand Wrung, ProCell Wrung; Procedure · Device
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years to 89 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Lung Injury, Pulmonary Complication
Interventions: Fraction of Inspired Oxygen; Other
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Atrial Fibrillation
Interventions: Omega Three Polyunsaturated fatty acids; Drug
Lead sponsor: Chirag Sandesara; Other
Eligibility: 18 Years to 85 Years
Enrollment: 260 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Saphenous Vein Graft Disease
Interventions: Aspirin, Ticagrelor; Drug
Lead sponsor: Boca Raton Regional Hospital; Other
Eligibility: 18 Years to 90 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2021
U.S. locations: 1
States / cities: Boca Raton, Florida

Conditions: Coronary Artery Diseases, Valvular Heart Diseases
Interventions: Reiki/manual therapy; Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 272 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Off Pump Coronary Artery Bypass Surgery
Interventions: Vacuum Stabilizer System, Vacuum Positioner System, Blower/Mister, Proximal Seal System; Device
Lead sponsor: Maquet Cardiovascular; Industry
Eligibility: 22 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 2
States / cities: Stockton, California • Wausau, Wisconsin

Conditions: Disorder of Vitamin C, Atrial Fibrillation, Complications Due to Coronary Artery Bypass Graft, Heart Valve Disease
Interventions: Ascorbic Acid, Placebo; Drug
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Delirium, Congenital Heart Disease, Coronary Artery Disease, Heart Valve Disease
Interventions: Remote ischemic pre-conditioning, Delirium Assessment; Procedure · Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 65 Years and older
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Coronary Artery Disease
Interventions: Hybrid Coronary Revascularization (HCR), Coronary Artery Bypass Grafting (CABG); Procedure
Lead sponsor: Emory University; Other
Eligibility: Not listed
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Atlanta, Georgia

Search by objective public record fields.

Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery

The Use of Aging Biomarkers to Predict Adverse Outcomes After Cardiac Surgery

A Single Center Clinical Evaluation of Same Sitting Hybrid Revascularization: Robotic Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention for the Treatment of Coronary Artery Disease

BrainProtect-guided, Real-time Cerebral Autoregulation Monitoring and Protection of Brain During Cardiac Surgery With Cardiopulmonary Bypass Requiring Heart-lung Machine

Randomization of Single vs Multiple Arterial Grafts

Effectiveness of BoneSeal® on Bone Hemostats in Patients Undergoing Cardiothoracic Surgery

Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass

Analysis of Red Blood Cell Integrity and Efficiency of Recovery Using a Novel Surgical Sponge-Blood Recovery Device (ProCell): Delayed Impact

A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery

Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) 3 Extended

Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Coronary Artery Bypass Graft (CABG) Patients

HiCM-188 Cell Therapy in Adults With Advanced Heart Failure Undergoing Heart Bypass Surgery

Using WHOOP Fitness Band to Measure Heart Health Variability Before and After Surgery

REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women

A Study Comparing the Efficacy and Safety of Valdecoxib Plus Parecoxib Versus Valdecoxib Plus Placebo for the Treatment of Pain After Coronary Artery Bypass Surgery

Analysis of Red Blood Cell Integrity and Efficiency of Recovery Using a Novel Surgical Sponge-Blood Recovery Device (ProCell)

Intra-operative Fraction of Inspired Oxygen and Lung Injury in Coronary Artery Bypass Grafting Surgery

Fish Oil for Reduction of Atrial Fibrillation After Cardiac Surgery

Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis

Clinical and Hospital Stay Effects of Reiki and Manual Therapy After Open Heart Surgery

Getinge's Beating Heart Product Family Post-Market Clinical Follow-up (PMCF) Study

High Dose Vitamin C in Cardiac Surgery Patients

An Intervention to Reduce Delirium After Cardiac Surgery

HCR vs. CABG Study